Bill Gates once claimed that, “In the next few decades, millions will most likely die not due to war or missiles, but microbes.” And we share the same course to ensure these potential epidemics are addressed as soon as possible.
Last September, world leaders at the Sustainable Development Summit of the United Nations adopted 17 goals with broad intentions raging from social justice to ending poverty. One of the goals, Sustainable Development Goal 3, “Aspires to ensure health and well-being for all, including a bold commitment to end the epidemics of AIDS, tuberculosis, malaria, and other neglected tropical disease as well as communicable diseases by 2030,” something that is closely related to the vission and mission AIME shares.
Although successful efforts have been made in decreasing the spread of deadly diseases—such as over the last decade, new HIV infections have decreased by close to a million, and the mortality rate for malaria has fallen by 58%, these illnesses still affect millions every year. They mutate and evolve and that scares us, from dengue to zika…and whats next?
Take dengue for an instance, one of the vector borne diseases the UN is trying to address and AIME is in the midst of tackling them. About 40% of the world’s population is at risk of contracting the disease. With the amount of world travel and fast trade between countries, that’s a frightening figure. The potential of a widespread epidemic is completely possible.
We’re thrilled and lucky to be part of successful entity that’s focuses in curbing the spread of these dangerous diseases and to help not just make the goals of the UN possible, but to make them actually happen. Our platform is able to provide its users with the exact geo location and date of the next dengue outbreak, 3 months in advance and with an 86.37% accuracy, we’re looking forward to eventually apply our model for AIDS, Tuberculosis, Malaria, and other neglected tropical diseases that the UN and AIME are both hoping to end.
We know it’s possible, and we know it’s the right thing to do. We’ve always considered ourselves an epidemiology company first, and a tech company second. So here’s to the last few years of research into making our flagship Dengue Outbreak Prediction platform possible, and to many more of making that platform usable for other diseases that have plagued our society for decades.